Leo Ungar, MD
Cardiac Electrophysiology · Pasadena
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Foothill Cardiology Medical Group Inc · 36 clinicians in this group
Hospitals listed: Cedars-Sinai Medical Center · Emanate Health Inter-Community Hospital · Huntington Hospital · USC Arcadia Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ungar’s office at (626) 793-4139 to ask if they take your plan before you enroll.
California Medical Board record
Licence A139457 · Current
Licensed to practise in California · since 2015 · expires 2027-03-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Cedars-Sinai Medical CenterLos Angeles, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Postoperative sepsis rate: 7.77 (6.11 to 9.44) · 6,132 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.2 to 14.7) · 1,174 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 134.15 (109.33 to 158.98) · 557 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.386, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.661, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.628, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.503, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.8 (3 to 4.8) · 1,174 cases, Jan 2024 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.8) · 2,580 cases, Jan 2024 – Dec 2024
- Emanate Health Inter-Community HospitalCovina, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Emanate Health, which runs 3 hospitalsPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025
- Huntington HospitalPasadena, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- USC Arcadia HospitalArcadia, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of University of Southern California, which runs 4 hospitalsPatients rate it 2 of 5 · 62% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.545, Oct 2024 – Sep 2025
See every measure and the patient survey for Cedars-Sinai Medical Center
Behind the star rating — Deaths: 7 better, 1 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 7.77 (6.11 to 9.44) · 6,132 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.2 to 14.7) · 1,174 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.15 (109.33 to 158.98) · 557 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.386 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.661 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.628 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.503 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 3.8 (3 to 4.8) · 1,174 cases | Better | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.8) · 2,580 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.66 (0.06 to 1.25) · 8,257 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.92 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 223 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 5.9 · 191 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.3 · 409 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 5.5 · 1,544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.5 · 1,742 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 549 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.3 · 9,504 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.28) · 29,170 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.05 to 0.32) · 31,661 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.1 (3.06 to 5.14) · 11,199 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0.47 to 2.29) · 6,024 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.05 (1.24 to 2.86) · 10,075 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.2 (5.76 to 10.65) · 6,012 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.91 (0.72 to 3.11) · 2,803 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.75 (0.47 to 1.03) · 27,865 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 472 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.437 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.168 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 492 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 1,750 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.9 · 498 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.8 · 1,908 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.7 · 1,850 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 1,572 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.7 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 172 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 240 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.1 to 17.5) · 1,197 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,081 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Emanate Health Inter-Community Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 2 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.4 (0.39 to 2.4) · 990 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.53 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.56 (145.92 to 251.21) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 99 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.8 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 665 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.3 · 389 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 3,599 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,844 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.42) · 6,958 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.21 (0.98 to 5.43) · 1,118 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.46 (0 to 3.08) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.05 (0.53 to 3.58) · 1,140 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.68 (1.69 to 15.67) · 450 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.07 (1.14 to 9) · 397 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 0.97) · 5,698 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 213 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.578 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.853 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.438 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.205 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 352 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 631 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2 · 136 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 336 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.2 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,007 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.5 to 8) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (8.8 to 16.5) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.6) · 113 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 106 cases | No different | Jan 2024 – Dec 2024 |
What patients said (924 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Huntington Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 1 better, 6 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.68 (0 to 1.56) · 2,225 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 149.43 (106.58 to 192.28) · 128 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 67 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.8 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 475 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.7 · 822 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 463 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 5,850 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.36) · 10,123 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 10,515 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.4 (2.67 to 6.13) · 2,613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.32 (0 to 2.86) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.44 to 4.11) · 2,457 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.71 (1.95 to 13.48) · 1,211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.08 (0.8 to 7.36) · 1,189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.85 (0.42 to 3.29) · 825 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0.03 to 1.09) · 8,956 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 269 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.448 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.977 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.423 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 253 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.9 · 846 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 5.2 · 176 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.1 · 542 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.5 · 864 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 1,144 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.2 to 8.5) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 15.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 260 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 201 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.8 to 15.8) · 365 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 786 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,430 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for USC Arcadia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.545 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.76) · 1,417 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.27 (0.97 to 1.58) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.26 (152.13 to 228.39) · 89 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.6 · 93 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.3 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 413 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.9 · 432 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 3,815 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.45) · 6,579 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.39) · 6,907 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.52 (1.51 to 5.53) · 1,534 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.88 (0.26 to 3.51) · 534 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.97 to 3.94) · 1,486 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.28 (8.51 to 22.05) · 562 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.95 (4.26 to 11.64) · 512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.29 (0.81 to 3.77) · 479 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.7 (0.11 to 1.29) · 5,994 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.9 · 285 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.652 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.331 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.694 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.145 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 196 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.9 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.9 · 487 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 28.1 · 723 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 863 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.4 · 308 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 155 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.5 to 16.9) · 408 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 538 cases | No different | Jan 2024 – Dec 2024 |
What patients said (560 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 62% |
| Staff "always" explained possible side effects | 34% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$182,645
Medicare paid this office $182,645 for 1,889 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 233 | $35,385 | $96 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $16,142 | $769 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,505 | $13,864 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $10,238 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $9,863 | $133 |
See all 16 services
| Return visit (30+ min) | 233 | $35,385 | $96 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $16,142 | $769 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,505 | $13,864 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $10,238 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $9,863 | $133 |
| Long return visit (40+ min) | 39 | $6,435 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 75 | $6,384 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 224 | $3,894 | $11 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 40 | $3,737 | $21 |
| New patient visit (45+ min) | 27 | $3,316 | $123 |
| Critical care, first 30-74 minutes | 15 | $3,124 | $174 |
| Programming of single lead pacemaker system | 25 | $1,925 | $55 |
| Programming of dual lead pacemaker system | 16 | $1,127 | $63 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 29 | $1,109 | $22 |
| Short return visit (20+ min) | 11 | $714 | $65 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 21 | $441 | $21 |
Procedures Medicare counted
| Pacemaker insertion or repair | 28 | More than 77% of doctors who do this |
Who their Medicare patients are
1,889 Original Medicare patients in 2024. Average age 77 · Under 65 7% · 85 and older 25% · Women 53% · Also on Medicaid 39% · Health risk score 2.35. Sicker patients than 9 in 10 peers; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Coronary heart disease 56% · Diabetes 48% · Heart failure 45% · Atrial fibrillation 43% · Chronic kidney disease 42% · Depression 34% · COPD 29% · Dementia 26% · Cancer 22% · Stroke 20%.
The office billed $699,955, Medicare allowed $241,905 and paid $182,645; for 3,736 services of 62 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,889 | 3,736 | 77 | 2.35 | $699,955 | $182,645 |
| 2023 | 2,120 | 4,285 | 77 | 2.14 | $895,271 | $246,746 |
| 2022 | 132 | 305 | 78 | 1.82 | $106,409 | $33,459 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Insertion of heart rhythm monitor under skin | 17 | $69,648 | $4,097 |
| Return visit (30+ min) | 198 | $37,416 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $17,628 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 116 | $17,490 | $98 |
| Long return visit (40+ min) | 81 | $17,125 | $144 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,745 | $16,042 | $7 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 11 | $8,669 | $788 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $7,226 | $66 |
| New patient visit (45+ min) | 49 | $6,572 | $134 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 242 | $5,918 | $12 |
| Insertion of permanent leadless pacemaker using imaging guidance | 16 | $5,797 | $362 |
| Short return visit (20+ min) | 39 | $3,298 | $73 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 30 | $2,683 | $22 |
| Critical care, first 30-74 minutes | 11 | $2,298 | $177 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,633 | $109 |
| Programming of single lead pacemaker system | 18 | $1,406 | $61 |
| External shock to heart to regulate heart beat | 15 | $1,182 | $79 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 16 | $575 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $248 | $18 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $235 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $163 | $12 |
2022: 7 services
| Long return visit (40+ min) | 29 | $5,728 | $155 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,639 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $3,227 | $60 |
| Return visit (30+ min) | 22 | $2,956 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,374 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 52 | $943 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 20 | $160 | $7 |
Medicaid work
$24,666 in 2024
Medicaid paid $24,666 for 2,437 billed services this clinician did in 2024, up to 266 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,088 | $14,637 |
| Return visit (30+ min) | 159 | $8,617 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 190 | $1,412 |
| 2024 | 2,437 | 3 | 266 | $24,666 |
| 2023 | 2,174 | 4 | 222 | $21,780 |
| 2022 | 26 | 1 | 23 | $210 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,789 | $9,779 |
| Return visit (30+ min) | 106 | $7,738 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 261 | $3,535 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 18 | $727 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 26 | $210 |
Drugs they prescribed that Part D paid
$1,321,146
Pharmacies billed $1,321,146 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,548 generic and 812 brand-name prescriptions · $1,321,146 in drug cost · 42 antibiotic prescriptions to 32 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyndamax | 21 | $459,129 | $21,863 |
| Eliquis | 399 | $440,862 | $1,105 |
| Xarelto | 103 | $126,486 | $1,228 |
| Entresto | 89 | $100,427 | $1,128 |
| Farxiga | 49 | $46,386 | $947 |
See all 28 drugs
| Vyndamax | 21 | $459,129 | $21,863 |
| Eliquis | 399 | $440,862 | $1,105 |
| Xarelto | 103 | $126,486 | $1,228 |
| Entresto | 89 | $100,427 | $1,128 |
| Farxiga | 49 | $46,386 | $947 |
| Multaq | 38 | $45,048 | $1,185 |
| Jardiance | 39 | $43,353 | $1,112 |
| Amiodarone | 146 | $9,234 | $63 |
| Flecainide Acetate | 99 | $6,375 | $64 |
| Metoprolol | 253 | $4,006 | $16 |
| Rosuvastatin | 220 | $3,998 | $18 |
| Theo-24 | 13 | $3,835 | $295 |
| Carvedilol | 241 | $2,296 | $10 |
| Theophylline Er | 11 | $1,805 | $164 |
| Diltiazem 24hr Er | 50 | $1,709 | $34 |
| Ranolazine Er | 19 | $1,613 | $85 |
| Amlodipine Besylate | 126 | $929 | $7 |
| Ezetimibe | 34 | $765 | $22 |
| Atorvastatin | 83 | $743 | $9 |
| Diltiazem 24hr Er (Cd) | 18 | $550 | $31 |
| Spironolactone | 34 | $349 | $10 |
| Isosorbide Mononitrate Er | 16 | $247 | $15 |
| Clopidogrel | 16 | $184 | $12 |
| Sucralfate | 12 | $137 | $11 |
| Doxycycline Hyclate | 39 | $104 | $3 |
| Furosemide | 19 | $67 | $4 |
| Pantoprazole | 15 | $60 | $4 |
| Lisinopril | 22 | $55 | $2 |
Year by year
| 2024 | 2,360 | 496 | None | 34% | $1,321,146 |
| 2023 | 1,324 | 345 | 0% (0) | 27% | $466,139 |
| 2022 | 154 | 97 | 0% (0) | None | $98,021 |
| 2021 | 135 | 85 | None | None | $10,133 |
| 2020 | 65 | 41 | None | None | $4,041 |
| 2019 | 30 | None | 0% (0) | 47% | $5,911 |
| 2018 | 37 | 21 | None | None | $3,123 |
| 2017 | 39 | None | 0% (0) | 33% | $3,596 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Eliquis | 196 | $221,765 | $1,131 |
| Entresto | 49 | $48,901 | $998 |
| Xarelto | 24 | $29,087 | $1,212 |
| Farxiga | 23 | $27,316 | $1,188 |
| Jardiance | 27 | $26,372 | $977 |
| Multaq | 13 | $22,353 | $1,719 |
| Amiodarone | 104 | $5,783 | $56 |
| Rosuvastatin | 128 | $4,290 | $34 |
| Metoprolol | 154 | $3,920 | $25 |
| Flecainide Acetate | 37 | $3,156 | $85 |
| Carvedilol | 151 | $2,778 | $18 |
| Ezetimibe | 16 | $1,856 | $116 |
| Atorvastatin | 85 | $1,428 | $17 |
| Diltiazem 24hr Er | 27 | $1,358 | $50 |
| Amlodipine Besylate | 93 | $984 | $11 |
| Diltiazem 24hr Er (Cd) | 14 | $776 | $55 |
| Potassium Chloride | 13 | $513 | $39 |
| Doxycycline Hyclate | 48 | $380 | $8 |
| Pantoprazole | 12 | $206 | $17 |
| Furosemide | 12 | $134 | $11 |
2022: 3 drugs
| Eliquis | 23 | $24,999 | $1,087 |
| Metoprolol | 23 | $524 | $23 |
| Pantoprazole | 14 | $153 | $11 |
2021: 4 drugs
| Amiodarone | 19 | $623 | $33 |
| Bisoprolol | 12 | $477 | $40 |
| Cephalexin | 45 | $368 | $8 |
| Pantoprazole | 14 | $163 | $12 |
2020: 1 drug
| Cephalexin | 31 | $263 | $8 |
Money from drug and device companies
$3,981 in 2025
| 2025 | 21 | 144 | None | $3,981 |
| 2024 | 23 | 170 | None | $5,187 |
| 2023 | 17 | 129 | None | $5,837 |
| 2022 | 7 | 29 | None | $2,279 |
| 2021 | 3 | 4 | None | $206 |
| 2020 | 2 | 2 | None | $169 |
| 2019 | 4 | 28 | None | $3,326 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Micra | $1,439 | 27 payments
|
| Boston Scientific | General - Tachy | $701 | 41 payments
|
| Merck Sharp & Dohme | Verquvo | $245 | 9 payments
|
| Pfizer | Vyndaqel | $230 | 11 payments
|
| Kestra Medical Technology Services | Assure Wcd | $230 | 18 payments
|
| Cordis US | Mynx Control Venous | $209 | 9 payments
|
See all 144 published payments
| Boston Scientific | Meals · 2025-12-31 | General - Tachy | $87 |
| Boston Scientific | Meals · 2025-12-29 | General - Tachy | $6 |
| Cordis US | Meals · 2025-12-29 | Mynx Control Venous | $12 |
| Ethicon US | Meals · 2025-12-23 | Stratafix | $29 |
| Boston Scientific | Meals · 2025-12-22 | Emblem Mri S-Icd | $6 |
| Liquidia Technologies | Meals · 2025-12-17 | Yutrepia | $28 |
| Kestra Medical Technology Services | Meals · 2025-12-17 | Assure Wcd | $18 |
| Boston Scientific | Meals · 2025-12-11 | Watchman Flx | $32 |
| Boston Scientific | Meals · 2025-12-11 | Accolade Sr | $4 |
| Boston Scientific | Meals · 2025-12-11 | General - Tachy | $119 |
| Kestra Medical Technology Services | Meals · 2025-12-11 | Assure Wcd | $2 |
| Boston Scientific | Meals · 2025-12-09 | Accolade Sr | $5 |
| Boston Scientific | Meals · 2025-12-02 | Accolade Sr | $6 |
| Kestra Medical Technology Services | Meals · 2025-11-26 | Assure Wcd | $5 |
| Abbott Laboratories | Meals · 2025-11-25 | Viewmate | $21 |
| Kestra Medical Technology Services | Meals · 2025-11-25 | Assure Wcd | $25 |
| Medtronic | Meals · 2025-11-21 | Micra | $173 |
| Kestra Medical Technology Services | Meals · 2025-11-21 | Assure Wcd | $17 |
| Pfizer | Meals · 2025-11-20 | Vyndaqel | $20 |
| Kestra Medical Technology Services | Meals · 2025-11-20 | Assure Wcd | $2 |
| Medtronic | Meals · 2025-11-19 | Reveal Linq | $13 |
| Kestra Medical Technology Services | Meals · 2025-11-17 | Assure Wcd | $6 |
| Boston Scientific | Meals · 2025-11-13 | Watchman Flx | $4 |
| Boston Scientific | Meals · 2025-11-13 | Watchman Flx | $23 |
| Boston Scientific | Meals · 2025-11-12 | Watchman Flx | $4 |
| Boston Scientific | Meals · 2025-11-12 | Watchman Flx | $3 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-12 | Kerendia | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-11-11 | Lifevest | $16 |
| Boston Scientific | Meals · 2025-11-07 | Farapulse | $9 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-06 | Wainua | $32 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-11-04 | Lifevest | $18 |
| Boston Scientific | Meals · 2025-10-30 | Latitude Communicator Power Supply | $16 |
| Cordis US | Meals · 2025-10-30 | Mynx Control Venous | $19 |
| Boston Scientific | Meals · 2025-10-28 | Accolade Sr | $5 |
| Boston Scientific | Meals · 2025-10-27 | Accolade Sr | $5 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-24 | Kerendia | $123 |
| Merck Sharp & Dohme | Meals · 2025-10-22 | Capvaxive | $30 |
| Boston Scientific | Meals · 2025-10-21 | Emblem Mri S-Icd | $7 |
| Cordis US | Meals · 2025-10-20 | Mynx Control Venous | $15 |
| Abbott Laboratories | Meals · 2025-10-16 | Amplatzer Amulet | $6 |
| Novo Nordisk | Meals · 2025-10-11 | Rybelsus | $17 |
| Inspire Medical Systems | Meals · 2025-10-09 | Inspire | $23 |
| Medtronic | Meals · 2025-10-07 | Micra | $25 |
| Cordis US | Meals · 2025-10-06 | Mynx Control Venous | $21 |
| Boston Scientific | Meals · 2025-09-30 | Accolade Sr | $6 |
| Kestra Medical Technology Services | Meals · 2025-09-30 | Assure Wcd | $21 |
| Boston Scientific | Meals · 2025-09-29 | Accolade Sr | $7 |
| Boston Scientific | Meals · 2025-09-23 | Accolade Sr | $5 |
| Boston Scientific | Meals · 2025-09-19 | Accolade Sr | $7 |
| Medtronic | Meals · 2025-09-19 | Micra | $26 |
| Kestra Medical Technology Services | Meals · 2025-09-17 | Assure Wcd | $22 |
| Boston Scientific | Meals · 2025-09-11 | Accolade Sr | $4 |
| Merck Sharp & Dohme | Meals · 2025-09-09 | Verquvo | $27 |
| Boston Scientific | Meals · 2025-09-04 | Accolade Sr | $7 |
| Medtronic | Meals · 2025-09-04 | Micra | $9 |
| Amgen | Meals · 2025-09-02 | Repatha | $23 |
| Kestra Medical Technology Services | Meals · 2025-08-29 | Assure Wcd | $19 |
| Boston Scientific | Meals · 2025-08-27 | Accolade Sr | $24 |
| Merck Sharp & Dohme | Meals · 2025-08-27 | Verquvo | $24 |
| Medtronic | Meals · 2025-08-26 | Mycarelink | $13 |
| Medtronic | Meals · 2025-08-26 | Micra | $29 |
| Medtronic | Meals · 2025-08-25 | Micra | $19 |
| Boston Scientific | Meals · 2025-08-15 | Accolade Sr | $4 |
| Boston Scientific | Meals · 2025-08-13 | Accolade Sr | $6 |
| Cordis US | Meals · 2025-08-07 | Mynx Control Venous | $23 |
| Kestra Medical Technology Services | Meals · 2025-08-07 | Assure Wcd | $9 |
| Boston Scientific | Meals · 2025-08-04 | Accolade Sr | $6 |
| Pfizer | Meals · 2025-07-29 | Vyndaqel | $29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-18 | Lifevest | $16 |
| Boston Scientific | Meals · 2025-07-15 | Accolade Sr | $10 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-10 | Wainua | $34 |
| Pfizer | Meals · 2025-07-08 | Eliquis | $19 |
| Boston Scientific | Meals · 2025-07-03 | Accolade Sr | $6 |
| Medtronic | Meals · 2025-06-24 | Onyx Frontier | $24 |
| Kestra Medical Technology Services | Meals · 2025-06-24 | Assure Wcd | $7 |
| Medtronic | Meals · 2025-06-20 | Onyx Frontier | $9 |
| Boston Scientific | Meals · 2025-06-19 | Farapulse | $102 |
| Impulse Dynamics (USA) | Meals · 2025-06-18 | Optimizer | $7 |
| Merck Sharp & Dohme | Meals · 2025-06-18 | Verquvo | $33 |
| Boston Scientific | Meals · 2025-06-11 | Farapulse | $18 |
| AltaThera Pharmaceuticals | Meals · 2025-06-10 | Sotalol Hydrochloride | $16 |
| Medtronic | Meals · 2025-06-03 | Micra | $8 |
| Pfizer | Meals · 2025-06-03 | Eliquis | $22 |
| Kestra Medical Technology Services | Meals · 2025-06-03 | Assure Wcd | $5 |
| Boston Scientific | Meals · 2025-06-02 | Accolade Sr | $28 |
| Medtronic | Meals · 2025-06-02 | Micra | $8 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-30 | Lifevest | $6 |
| Boston Scientific | Meals · 2025-05-30 | Acuity Steerable | $23 |
| Kestra Medical Technology Services | Meals · 2025-05-29 | Assure Wcd | $30 |
| Medtronic | Travel · 2025-05-28 | None | $788 |
| Medtronic | Meals · 2025-05-28 | Micra | $64 |
| Kestra Medical Technology Services | Meals · 2025-05-28 | Assure Wcd | $22 |
| Cordis US | Meals · 2025-05-27 | Mynx Control | $32 |
| Medtronic | Meals · 2025-05-22 | Micra | $5 |
| Boston Scientific | Meals · 2025-05-16 | General - Therapies | $21 |
| Medtronic | Meals · 2025-05-14 | Micra | $17 |
| Boston Scientific | Meals · 2025-05-13 | Emblem Mri S-Icd | $8 |
| Medtronic | Meals · 2025-05-09 | Micra | $8 |
| Medtronic | Meals · 2025-05-07 | Aurora Ev-Icd Mri Surescan | $5 |
| Inspire Medical Systems | Meals · 2025-05-05 | Inspire | $18 |
| Pfizer | Meals · 2025-04-22 | Eliquis | $24 |
| Medtronic | Meals · 2025-04-19 | Cobalt Dr Mri Surescan | $29 |
| Merck Sharp & Dohme | Meals · 2025-04-15 | Verquvo | $27 |
| Medtronic | Meals · 2025-04-12 | Micra | $25 |
| Pfizer | Meals · 2025-04-11 | Vyndaqel | $18 |
| Cordis US | Meals · 2025-04-09 | Mynx Control Venous | $19 |
| Novartis Pharmaceuticals | Meals · 2025-04-08 | Leqvio | $26 |
| Impulse Dynamics (USA) | Meals · 2025-04-07 | Optimizer | $180 |
| Medtronic | Meals · 2025-04-03 | Cobalt Dr Mri Surescan | $5 |
| Cordis US | Meals · 2025-04-02 | Mynx Control Venous | $19 |
| Medtronic | Meals · 2025-03-31 | Aurora Ev-Icd Mri Surescan | $27 |
| Medtronic | Meals · 2025-03-20 | Micra | $6 |
| Medtronic | Meals · 2025-03-17 | Micra | $21 |
| Boston Scientific | Meals · 2025-03-13 | Watchman Flx | $23 |
| Pfizer | Meals · 2025-03-11 | Vyndaqel | $21 |
| Boston Scientific | Meals · 2025-03-10 | Emblem Mri S-Icd | $6 |
| Cardiva Medical | Meals · 2025-03-06 | Cardiva Vascade Mvp Xl Vvcs 10-12f | $25 |
| Merck Sharp & Dohme | Meals · 2025-03-05 | Verquvo | $34 |
| Merck Sharp & Dohme | Meals · 2025-03-04 | Verquvo | $23 |
| Abbott Laboratories | Meals · 2025-03-04 | Aveir | $127 |
| Medtronic | Meals · 2025-03-03 | Linq II | $5 |
| W. L. Gore & Associates | Meals · 2025-03-03 | Gore Cardioform Septal Occluder | $16 |
| Boston Scientific | Meals · 2025-02-28 | General - Brady | $15 |
| Cardiva Medical | Meals · 2025-02-28 | Cardiva Vascade Mvp Xl Vvcs 10-12f | $16 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-02-18 | Lifevest | $6 |
| Boston Scientific | Meals · 2025-02-18 | Emblem Mri S-Icd | $12 |
| Medtronic | Meals · 2025-02-18 | Micra | $63 |
| Cordis US | Meals · 2025-02-12 | Mynx Control Venous | $48 |
| Merck Sharp & Dohme | Meals · 2025-02-12 | Verquvo | $26 |
| Pfizer | Meals · 2025-02-11 | Eliquis | $20 |
| Cardiva Medical | Meals · 2025-02-06 | Cardiva Vascade Mvp Vvcs 6-12f | $23 |
| Abbott Laboratories | Meals · 2025-02-06 | Jot Dx | $17 |
| Cardiva Medical | Meals · 2025-02-01 | Cardiva Vascade Mvp Vvcs 6-12f | $14 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-30 | Jardiance | $28 |
| Merck Sharp & Dohme | Meals · 2025-01-29 | Verquvo | $22 |
| Boston Scientific | Meals · 2025-01-28 | Accolade Sr | $8 |
| Pfizer | Meals · 2025-01-27 | Vyndaqel | $17 |
| Boston Scientific | Meals · 2025-01-14 | Accolade Sr | $6 |
| Pfizer | Meals · 2025-01-10 | Vyndaqel | $17 |
| Kestra Medical Technology Services | Meals · 2025-01-08 | Assure Wcd | $4 |
| Medtronic | Meals · 2025-01-07 | Micra | $16 |
| Pfizer | Meals · 2025-01-07 | Eliquis | $23 |
| Kestra Medical Technology Services | Meals · 2025-01-03 | Assure Wcd | $0 |
| Kestra Medical Technology Services | Meals · 2025-01-03 | Assure Wcd | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $5,187
| Abbott Laboratories | Aveir | $2,057 | 17 payments
|
| Boston Scientific | Emblem Mri S-Icd | $1,042 | 44 payments
|
| Novartis Pharmaceuticals | Entresto | $377 | 25 payments
|
| Pfizer | Vyndaqel | $339 | 13 payments
|
| Medtronic | Micra | $328 | 24 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $134 | 6 payments
|
| Merck Sharp & Dohme | Verquvo | $120 | 5 payments
|
| Novo Nordisk | Ozempic | $115 | 6 payments
|
| Lexicon Pharmaceuticals | None | $112 | 4 payments
|
| Atricure | Atriclip Laa Exclusion System | $108 | 1 payment
|
| Alnylam Pharmaceuticals | Amvuttra | $90 | 4 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $77 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $54 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $52 | 3 payments
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $25 | 1 payment
|
| Philips North America | (5044) Mcot | $24 | 1 payment
|
| Lilly USA | Mounjaro | $22 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Wainua | $19 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $19 | 1 payment
|
| W. L. Gore & Associates | Gore Cardioform Septal Occluder | $18 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $17 | 1 payment
|
| Amgen | Repatha | $17 | 1 payment
|
2023: $5,837
| Abbott Laboratories | Aveir | $3,059 | 14 payments
|
| Medtronic | Micra | $813 | 11 payments
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $624 | 23 payments
|
| Boston Scientific | Emblem Mri S-Icd | $451 | 33 payments
|
| Novartis Pharmaceuticals | Leqvio | $287 | 18 payments
|
| Pfizer | Vyndaqel | $104 | 6 payments
|
| Lexicon Pharmaceuticals | Inpefa | $82 | 4 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $69 | 3 payments
|
| Alnylam Pharmaceuticals | Amvuttra | $65 | 3 payments
|
| Lilly USA | Mounjaro | $62 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $49 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $44 | 2 payments
|
| Esperion Therapeutics | Nexletol | $41 | 2 payments
|
| Amgen | Repatha | $40 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $16 | 1 payment
|
| Philips Electronics North America | (5050) Extended Holter | $14 | 1 payment
|
2022: $2,279
| Medtronic | Micra | $1,423 | 10 payments
|
| Abbott Laboratories | Aveir | $431 | 8 payments
|
| Boston Scientific | Resonate El Icd Vr | $317 | 6 payments
|
| Impulse Dynamics (USA) | Optimizer | $48 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $28 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $12 | 1 payment
|
2021: $206
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $93 | 1 payment
|
| Boston Scientific | S Icd | $57 | 1 payment
|
| Baylis Medical Company | Versacross Access Solution | $56 | 2 payments
|
2020: $169
| Boston Scientific | General - Therapies | $138 | 1 payment
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $31 | 1 payment
|
2019: $3,326
| Abbott Laboratories | Ensite Cardiac Mapping System | $3,187 | 25 payments
|
| Pfizer | Vyndaqel | $110 | 1 payment
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $18 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 99.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1851702088
- Licence
- CA A139457California A139457: Current · expires 2027-03-31
- Trained
- Stanford University School of Medicine, 2014
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X); Student in a training program (390200000X)
- Mailing address
- 3452 E Foothill Blvd Ste 130, Pasadena, CA, 91107
- NPI first listed
- 2014-05-09
- NPI last updated
- 2022-07-28
- NPI record certified
- 2022-07-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 315 N 3rd Ave Ste 207, Covina, CA, 91723 · 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.